Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
Endothelial injury and microvascular/macrovascular thrombosis are common
pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal …
pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal …
COVID-19 vasculitis and novel vasculitis mimics
COVID-19 has been occasionally linked to histologically confirmed cutaneous vasculitis and
a Kawasaki-like vasculitis, with these entities generally having minimal or no lung …
a Kawasaki-like vasculitis, with these entities generally having minimal or no lung …
SARS-CoV-2 initiates programmed cell death in platelets
M Koupenova, HA Corkrey, O Vitseva… - Circulation …, 2021 - Am Heart Assoc
Rationale: Coronavirus disease 2019 (COVID-19) is characterized by increased incidence
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear …
Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses
N Mackman, S Antoniak, AS Wolberg… - … , and vascular biology, 2020 - Am Heart Assoc
The world is amid a pandemic caused by severe acute respiratory syndrome-coronavirus 2.
Severe acute respiratory syndrome-coronavirus causes serious respiratory tract infections …
Severe acute respiratory syndrome-coronavirus causes serious respiratory tract infections …
Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist
A Zakeri, AP Jadhav, BA Sullenger… - Journal of …, 2021 - jnis.bmj.com
Coronavirus disease 2019 (COVID-19) results from infection by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It was first reported in Wuhan, China in patients …
syndrome coronavirus 2 (SARS-CoV-2). It was first reported in Wuhan, China in patients …
Platelets and SARS-CoV-2 during COVID-19: immunity, thrombosis, and beyond
A Sciaudone, H Corkrey, F Humphries… - Circulation …, 2023 - Am Heart Assoc
COVID-19 is characterized by dysregulated thrombosis and coagulation that can increase
mortality in patients. Platelets are fast responders to pathogen presence, alerting the …
mortality in patients. Platelets are fast responders to pathogen presence, alerting the …
[HTML][HTML] Is there a role for the ACE2 receptor in SARS‐CoV‐2 interactions with platelets?
RA Campbell, E Boilard, MT Rondina - Journal of Thrombosis and …, 2021 - Elsevier
There is an urgent need to understand the underlying mechanisms contributing to
thrombotic and inflammatory complications during COVID‐19. Data from independent …
thrombotic and inflammatory complications during COVID‐19. Data from independent …
[HTML][HTML] Factores de riesgo asociados a mortalidad en pacientes adultos con neumonía por SARS-CoV-2 en un hospital público de Lima, Perú
MJM Rodríguez-Zúñiga, A Quintana-Aquehua… - Acta Médica …, 2020 - scielo.org.pe
Resumen RODRIGUEZ-ZUNIGA, Milton JM et al. Factores de riesgo asociados a mortalidad
en pacientes adultos con neumonía por SARS-CoV-2 en un hospital público de Lima, Perú …
en pacientes adultos con neumonía por SARS-CoV-2 en un hospital público de Lima, Perú …
Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
Vaccine-induced immune thrombotic thrombocytopenia (VITT; synonym, thrombosis with
thrombocytopenia syndrome, is associated with high-titer immunoglobulin G antibodies …
thrombocytopenia syndrome, is associated with high-titer immunoglobulin G antibodies …
[HTML][HTML] The role of platelets in sepsis
O Shannon - Research and practice in thrombosis and haemostasis, 2021 - Elsevier
A State of the Art lecture titled “The role of platelets in sepsis” was presented at the ISTH
congress in 2020. Sepsis is a life‐threatening organ dysfunction caused by a dysregulated …
congress in 2020. Sepsis is a life‐threatening organ dysfunction caused by a dysregulated …